Detalhe da pesquisa
1.
Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry.
J Med Virol
; 93(7): 4303-4318, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33666246
2.
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection.
Med
; 3(1): 28-41.e8, 2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927113
3.
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19.
PNAS Nexus
; 1(3): pgac082, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35832867
4.
Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19.
PNAS Nexus
; 1(2): pgac058, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713311
5.
Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection.
PNAS Nexus
; 1(2): pgac042, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713312
6.
Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients.
EClinicalMedicine
; 33: 100774, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718845
7.
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.
Med
; 2(8): 979-992.e8, 2021 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223401
8.
Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus.
EClinicalMedicine
; 34: 100793, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33778434
9.
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations.
Sci Rep
; 11(1): 4741, 2021 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637783
10.
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence.
medRxiv
; 2021 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34401884
11.
Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients.
Cell Death Discov
; 7(1): 55, 2021 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723251
12.
Mapping each pre-existing condition's association to short-term and long-term COVID-19 complications.
NPJ Digit Med
; 4(1): 117, 2021 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34315980
13.
Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines.
Med
; 2(8): 965-978.e5, 2021 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34230920
14.
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19.
medRxiv
; 2021 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34075387
15.
Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.
EClinicalMedicine
; 40: 101102, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485873
16.
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19.
J Clin Invest
; 131(19)2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411003
17.
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Elife
; 92020 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452762
18.
Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors.
Elife
; 92020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32463365
19.
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity.
Cell Death Discov
; 6(1): 138, 2020 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33298894
20.
Long-term SARS-CoV-2 RNA Shedding and its Temporal Association to IgG Seropositivity.
medRxiv
; 2020 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577666